Loss of apolipoprotein E exacerbates the neonatal lethality of the Smith-Lemli-Opitz syndrome mouse

Molecular Genetics and Metabolism

Volumn 91, Issue 1, 2007, Pages 7-14

  Solcà, Curzio ^a   Pandit, Bhaswati ^b   Yu, Hongwei ^a   Tint, G Stephen ^c   Patel, Shailendra B ^a,d  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Fetal development; Genetics; Maternal fetal transfer; RSH syndrome; Sterols

Indexed keywords

3BETA HYDROXYSTEROL DELTA7 REDUCTASE; APOLIPOPROTEIN E; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FETOMATERNAL TRANSFUSION; FETUS OUTCOME; GENETIC VARIABILITY; HYPERCHOLESTEROLEMIA; LETHALITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMITH LEMLI OPITZ SYNDROME;

ANIMALS; ANIMALS, NEWBORN; APOLIPOPROTEINS E; BRAIN; CHOLESTEROL; EMBRYO; FEMALE; GENES, LETHAL; GENOTYPE; HUMANS; LIVER; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PREGNANCY; SMITH-LEMLI-OPITZ SYNDROME; TRIGLYCERIDES;

MURINAE;

EID: 34047251013     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2006.11.009     Document Type: Article

References (40)

1. Opitz J.M. RSH/SLO ("Smith-Lemli-Opitz") syndrome: historical, genetic, and developmental considerations. Am. J. Med. Genet. 50 4 (1994) 344-346
2. Fitzky B.U., Witsch-Baumgartner M., Erdel M., Lee J.N., Paik Y.K., Glossmann H., Utermann G., and Moebius F.F. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc. Natl. Acad. Sci. USA 95 14 (1998) 8181-8186
3. Wassif C.A., Maslen C., Kachilele-Linjewile S., Lin D., Linck L.M., Connor W.E., Steiner R.D., and Porter F.D. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am. J. Hum. Genet. 63 1 (1998) 55-62
4. Waterham H.R., Wijburg F.A., Hennekam R.C., Vreken P., Poll-The B.T., Dorland L., Duran M., Jira P.E., Smeitink J.A., Wevers R.A., and Wanders R.J. Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. Am. J. Hum. Genet. 63 2 (1998) 329-338
5. Witsch-Baumgartner M., Fitzky B.U., Ogorelkova M., Kraft H.G., Moebius F.F., Glossmann H., Seedorf U., Gillessen-Kaesbach G., Hoffmann G.F., Clayton P., Kelley R.I., and Utermann G. Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am. J. Hum. Genet. 66 2 (2000) 402-412
6. Yu H., Tint G.S., Salen G., and Patel S.B. Detection of a common mutation in the RSH or Smith-Lemli-Opitz syndrome by a PCR-RFLP assay: IVS8-G -->C is found in over sixty percent of US propositi. Am. J. Med. Genet. 90 4 (2000) 347-350
7. Yu H., and Patel S.B. Recent insights into the Smith-Lemli-Opitz syndrome. Clin. Genet. 68 5 (2005) 383-391
8. Battaile K.P., Battaile B.C., Merkens L.S., Maslen C.L., and Steiner R.D. Carrier frequency of the common mutation IVS8-1G>C in DHCR7 and estimate of the expected incidence of Smith-Lemli-Opitz syndrome. Mol. Genet. Metab. 72 1 (2001) 67-71
9. Yu H., Tint G.S., Salen G., and Patel S.B. Detection of a Common Mutation in the RSH or Smith-Lemli-Opitz Syndrome by a PCR-RFLP assay. Am. J. Med. Genet. 90 (2000) 347-350
10. Yu H., Lee M.H., Starck L., Elias E.R., Irons M., Salen G., Patel S.B., and Tint G.S. Spectrum of Delta(7)-dehydrocholesterol reductase mutations in patients with the Smith-Lemli-Opitz (RSH) syndrome. Hum. Mol. Genet. 9 9 (2000) 1385-1391
11. Witsch-Baumgartner M., Gruber M., Kraft H.G., Rossi M., Clayton P., Giros M., Haas D., Kelley R.I., Krajewska-Walasek M., and Utermann G. Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome. J. Med. Genet. 41 8 (2004) 577-584
12. Davignon J., Gregg R.E., and Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8 1 (1988) 1-21
13. Eichner J.E., Kuller L.H., Orchard T.J., Grandits G.A., McCallum L.M., Ferrell R.E., and Neaton J.D. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am. J. Cardiol. 71 2 (1993) 160-165
14. Borgaonkar D.S., Schmidt L.C., Martin S.E., Kanzer M.D., Edelsohn L., Growdon J., and Farrer L.A. Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19. Lancet 342 8871 (1993) 625
15. Weisgraber K.H., Rall Jr. S.C., and Mahley R.W. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J. Biol. Chem. 256 17 (1981) 9077-9083
16. Ordovas J.M. Gene-diet interaction and plasma lipid response to dietary intervention. Curr. Atheroscler. Rep. 3 3 (2001) 200-208
17. Ordovas J.M., and Schaefer E.J. Treatment of dyslipidemia: genetic interactions with diet and drug therapy. Curr. Atheroscler. Rep. 1 1 (1999) 16-23
18. Smit M., de Knijff P., Rosseneu M., Bury J., Klasen E., Frants R., and Havekes L. Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum. Genet. 80 3 (1988) 287-292
19. Descamps O.S., Bruniaux M., Guilmot P.F., Tonglet R., and Heller F.R. Lipoprotein metabolism of pregnant women is associated with both their genetic polymorphisms and those of their newborn children. J. Lipid Res. 46 11 (2005) 2405-2414
20. Descamps O.S., Bruniaux M., Guilmot P.F., Tonglet R., and Heller F.R. Lipoprotein concentrations in newborns are associated with allelic variations in their mothers. Atherosclerosis 172 2 (2004) 287-298
21. Yoshida S., and Wada Y. Transfer of maternal cholesterol to embryo and fetus in pregnant mice. J. Lipid Res. 46 10 (2005) 2168-2174
22. Fitzky B.U., Moebius F.F., Asaoka H., Waage-Baudet H., Xu L., Xu G., Maeda N., Kluckman K., Hiller S., Yu H., Batta A.K., Shefer S., Chen T., Salen G., Sulik K., Simoni R.D., Ness G.C., Glossmann H., Patel S.B., and Tint G.S. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J. Clin. Invest. 108 6 (2001) 905-915
23. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., and Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92 2 (1993) 883-893
24. Ishibashi S., Goldstein J.L., Brown M.S., Herz J., and Burns D.K. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93 5 (1994) 1885-1893
25. Zhang S.H., Reddick R.L., Piedrahita J.A., and Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258 5081 (1992) 468-471
26. Zhang S.H., Reddick R.L., Burkey B., and Maeda N. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J. Clin. Invest. 94 3 (1994) 937-945
27. Yu H., Wessels A., Tint G.S., and Patel S.B. Partial rescue of neonatal lethality of Dhcr7 null mice by a nestin promoter-driven DHCR7 transgene expression. Brain Res. Dev. Brain Res. 156 1 (2005) 46-60
28. Kesaniemi Y.A., Ehnholm C., and Miettinen T.A. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J. Clin. Invest. 80 2 (1987) 578-581
29. Raffai R.L., Dong L.M., Farese Jr. R.V., and Weisgraber K.H. Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E. Proc. Natl. Acad. Sci. USA 98 20 (2001) 11587-11591
30. Witsch-Baumgartner M., Fitzky B.U., Ogorelkova M., Kraft H.G., Moebius F.F., Glossmann H., Seedorf U., Gillessen-Kaesbach G., Hoffmann G.F., Clayton P., Kelley R.I., and Utermann G. Mutational Spectrum in the Delta7-Sterol Reductase Gene and Genotype- Phenotype Correlation in 84 Patients with Smith-Lemli-Opitz Syndrome. Am. J. Hum. Genet. 66 2 (2000) 402-412
31. Newton-Cheh C., and Hirschhorn J.N. Genetic association studies of complex traits: design and analysis issues. Mutat. Res. 573 1-2 (2005) 54-69
32. Colhoun H.M., McKeigue P.M., and Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 361 9360 (2003) 865-872
33. Raabe M., Flynn L.M., Zlot C.H., Wong J.S., Veniant M.M., Hamilton R.L., and Young S.G. Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc. Natl. Acad. Sci. USA 95 15 (1998) 8686-8691
34. Farese Jr. R.V., Cases S., Ruland S.L., Kayden H.J., Wong J.S., Young S.G., and Hamilton R.L. A novel function for apolipoprotein B: lipoprotein synthesis in the yolk sac is critical for maternal-fetal lipid transport in mice. J. Lipid Res. 37 2 (1996) 347-360
35. Huang L.S., Voyiaziakis E., Markenson D.F., Sokol K.A., Hayek T., and Breslow J.L. Apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes. J. Clin. Invest. 96 5 (1995) 2152-2161
36. van Ree J.H., van den Broek W.J., Dahlmans V.E., Groot P.H., Vidgeon-Hart M., Frants R.R., Wieringa B., Havekes L.M., and Hofker M.H. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis 111 1 (1994) 25-37
37. Raffai R.L., and Weisgraber K.H. Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism. J. Biol. Chem. 277 13 (2002) 11064-11068
38. Chen Z., Fitzgerald R.L., and Schonfeld G. Hypobetalipoproteinemic mice with a targeted apolipoprotein (Apo) B-27.6-specifying mutation: in vivo evidence for an important role of amino acids 1254-1744 of ApoB in lipid transport and metabolism of the apoB-containing lipoprotein. J. Biol. Chem. 277 16 (2002) 14135-14145
39. Xu P.T., Schmechel D., Rothrock-Christian T., Burkhart D.S., Qiu H.L., Popko B., Sullivan P., Maeda N., Saunders A.M., Roses A.D., and Gilbert J.R. Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol. Dis. 3 3 (1996) 229-245
40. Sullivan P.M., Mezdour H., Quarfordt S.H., and Maeda N. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. J. Clin. Invest. 102 1 (1998) 130-135